This could occur directly via their effect on T lymphocytes, as evidenced, e.g., by an increased CD8+ component in tumor-infiltrating lymphocytes [30], or indirectly by altering the tumor microenvironment and cytokine milieu [16,31]. The gene discussed is CD8A; the disease is neoplasm.